S0860 — Compounded Drugs

S0860, a bill to define compounded medications and regulate their sale for weight loss, died in the Regulated Industries Committee on March 13, 2026.

The bill would have defined the term 'compounded medication' and prohibited any person or entity from selling, transferring, or distributing compounded medications for weight loss without providing specified documentation to the Department of Business and Professional Regulation. The bill would have established administrative penalties for violations.

Any person or entity engaged in the sale, transfer, or distribution of compounded medications for weight loss.

The bill did not become law; it died in committee on March 13, 2026, and is no longer under consideration in the 2026 legislative session.